Sign in

NCT06773065Recruiting

Central Awareness in Women With Endometriosis

The Role Of Central Sensitisation In Women With Endometriosis: A Prospective Observational Study

Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Gathering some information obtained during the gynaecological examination and transvaginal ultrasound check-up to be able to assess the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis and also to be able to assess related risk factors. CSS has been defined as an algic syndrome due to a hyperactivation of the sensitivity circuit at a central level; the diagnosis is based on the result obtained from a questionnaire, the Central Sensitisation Inventory (CSI), which evaluates the presence and intensity of 25 clinical symptoms. For this reason, a questionnaire is proposed to be completed at the time of the check-up visit.

Status (registry)
Recruiting
Study type
Observational
Enrollment
310 (estimated)
First submitted
1 Dec 2024
Start date
14 Jan 2022
Primary completion date
31 Jan 2025
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT number
NCT06773065

What you commit to

  • Study type: Observational
  • Planned participants: 310
  • From 14 Jan 2022 to the primary completion date, 31 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with poor compliance with hormone therapy, who are not taking it properly or have discontinued therapy spontaneously

Other illness

  • Positive history of any malignant neoplasm
  • Positive medical history of specific medical conditions that adversely affect the central nervous system, such as: brain or spinal cord damage, neurological diseases or peripheral nerve damage, multiple sclerosis

Other

  • Post-menopausal women (spontaneous or iatrogenic)
  • Virgo patients

Who the study is looking for

  • Women with a clinical, ultrasound and/or surgical diagnosis of endometriosis
  • Aged between 18 and 50 years
  • Patients starting or already taking hormone therapy
  • Patients coming for a first visit or outpatient follow-up visit
  • Signature of informed consent to participate in the study

Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Coordinator of this site? Confirm its status
BolognaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.